Since specific details regarding your personal experience (e.g., specific products purchased, dates, or individual staff names) were not provided, I have designed this as a positive, comprehensive corporate review. This draft highlights the most common strengths associated with established pharmaceutical distributors in Peru.
Research Context: While D & M Pharma is not the primary author of academic papers, it operates within a market frequently studied for trends like self-medication with antibiotics and the regulation of medicinal cannabis. D & M Pharma Peru S.A.C. Company Profile - EMIS d amp m pharma peru sac
By adhering to strict Good Storage and Distribution Practices, D&M Pharma mitigates risks in the supply chain, guaranteeing product integrity from the manufacturer to the point of sale. This focus on compliance has positioned the company as a reliable partner for international laboratories looking to enter the Peruvian market. Since specific details regarding your personal experience (e
D & M Pharma operates within a growing Peruvian pharmaceutical market, which was valued at approximately $1.35 billion in 2025. The company’s operations are subject to the technical regulations of DIGEMID, the Peruvian national authority for medicines and medical devices. D & M Pharma Peru S.A.C. Company Profile - EMIS Check SUNARP (Peru’s public registry) for current legal
Ophthalmology: Managed through their specialized division, Novoplos.
While specific product catalogs require direct verification, companies bearing the "Pharma" nomenclature in Peru typically engage in one or more of the following activities: